Cerebras Systems reaches the end of its initial public offering lock-up on Monday, 9 November, freeing the last of its locked shares for sale and putting the artificial intelligence chipmaker under fresh scrutiny just days before it reports quarterly results.

The final lock-up period ends on Monday, making the remaining locked shares eligible for sale going into Tuesday, 10 November. Shares becoming eligible for sale does not mean holders will sell, but the expiry removes the last formal barrier to insider selling after a staggered release schedule that has been freeing stock in waves since the company listed.

Cerebras, which builds AI computers around a processor cut from a whole silicon wafer, listed on the Nasdaq under the ticker CBRS on 14 May 2026, pricing its offering at 185 dollars a share and raising 5.55 billion dollars before the underwriters' option, making it one of the largest US technology listings of the year.

A lock-up that dissolved in waves

Unlike a standard 180-day freeze, Cerebras's lock-up was never a single expiry date. The IPO prospectus set out 11 separate release dates, with the first 10 freeing about 171 million shares by the company's own estimate, out of roughly 238 million shares outstanding. The final wave, which lands on Monday, covers everything still locked, and the company has not put a number on it.

The schedule works on whichever of two dates comes first: the second trading day after Cerebras reports third-quarter results, or 9 November, which falls 180 days after the date of the IPO prospectus. With results not due until Thursday, 12 November, Monday is the date that counts.

The unlock arrives after a bruising period for the stock. Cerebras shares have fallen 39% from their peak, according to Startup Fortune, as the wider AI trade has come under pressure and investors have questioned the durability of spending on AI infrastructure. Short interest ran above 11% of the float in mid-October.

Insiders have already been selling

Earlier unlock windows have already added pressure. Chief executive Andrew Feldman and chief technology officer Sean Lie sold more than 240 million dollars' worth of stock between 20 August and 25 September under pre-set trading plans, and the company's roughest stretches this year have run alongside the release calendar.

Not everyone is heading for the exit. ARK Invest, Cathie Wood's firm, disclosed buying Cerebras shares in trades dated 5 November, positioning ahead of the unlock. The contrast captures the divide over the stock: some investors see a supply event to avoid, others see a buying opportunity in a company still reporting rapid revenue growth.

Cerebras also announced plans on 27 October with Oracle to offer its AI inference technology through Oracle Cloud Infrastructure, a reminder that the commercial story has continued to develop even as the share price has fallen.

Results land three days later

The timing is tight. Cerebras reports third-quarter results after the market closes on Thursday, 12 November, and that report will have to carry the weight of expectations for 2027. Monday frees the shares; Thursday prices them, in the words of one analysis of the week ahead.

Investors will be watching whether the company can show that its backlog and its agreement with OpenAI support the growth implied by its valuation, and whether management gives a confident outlook for next year. A strong report could absorb the extra supply; a weak one, landing just as the last locked shares become sellable, could add to the pressure.

For now, the lock-up expiry is a supply event, not a demand event. Nothing in Monday's unlock changes the backlog, the OpenAI agreement or the company's technology. What it changes is who is allowed to sell, and in a market that has spent the past week punishing AI stocks, that is enough to keep traders watching closely.